focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks keep spirits up before Fed meets

Tue, 16th Mar 2021 10:04

* Graphic: Global asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates http://tmsnrt.rs/2egbfVh

By Ritvik Carvalho

LONDON, March 16 (Reuters) - World stocks rose on Tuesday,
as investors anticipated the U.S. Federal Reserve and other
central banks meeting this week will keep policies accommodative
to help drive a post-pandemic global economic recovery.

European shares extended a rally that began on Wall Street
on Monday and continued into Asia, with the pan-region STOXX 600
index up 0.5%. On Monday, the index touched
its highest level in more than a year before ending flat.

Britain's FTSE 100 index rose 0.7%, Germany's DAX
0.6%, France's CAC 40 0.2% and Italy's FTSE MIB index
0.6%.

E-mini futures for the S&P 500 hit a record high
before trading flat on the day.

MSCI's All Country World Index, which tracks stocks across
49 countries, rose 0.2% to its highest levels since Feb 25.

An index of Asia-Pacific share markets excluding Japan
gained 0.65%, led by a 0.8% jump in Australia's
benchmark S&P/ASX 200 index.

Japan's Nikkei 225 gained 0.5% to just below the
30,000 mark. The broader Topix added 0.65%.

China's blue-chip CSI 300 index climbed 0.87% and
Hong Kong's Hang Seng gained 0.67%.

"The stock markets have kept their spirits up ahead of
tomorrow's important Fed announcement," said Karl Steiner, chief
quantitative strategist at SEB.

On Monday, the S&P 500 and Dow Jones Industrial Average both
soared on gains in travel stocks as mass vaccinations in the
United States and congressional approval of a $1.9 trillion aid
bill fueled investor optimism.

Longer-term U.S. Treasury yields slipped further on
Tuesday, as the market looked ahead to government debt auctions
and the Fed's two-day policy meeting, which will conclude on
Wednesday.

The benchmark 10-year yield, which reached a
more than one-year high of 1.642% last week, was back at 1.125%.

The earlier surge in yields stemmed from investors
speculating that rising inflation expectations could prompt the
Federal Open Market Committee to signal it will start raising
rates sooner than expected.

"We think the FOMC will have a hard time expressing concern
about asset markets with the S&P at an all-time high on 12
March, despite 10Y U.S. Treasury yields at post-February 2020
highs," said analysts Steve Englander and John Davies at
Standard Chartered.

"Focus has been on the FOMC ‘dot plot’ in recent days, but
if the FOMC and Fed Chair (Jerome) Powell do not push back
against current yield levels, investors are likely to take
yields higher as better data arrives."

Fed policymakers are expected to forecast that the U.S.
economy will grow in 2021 by the fastest rate in decades, as it
recovers from a coronavirus-stricken 2020.

The Bank of England also meets this week on Thursday and the
Bank of Japan wraps up a two-day meeting on Friday.

On Wall Street, the Dow Jones Industrial Average rose
174.82 points, or 0.53%, to 32,953.46, the S&P 500 gained
25.6 points, or 0.65%, to 3,968.94 and the Nasdaq Composite
remained unchanged.

Airline shares rose as the companies pointed to
concrete signs of an industry recovery as vaccine rollouts help
spur leisure bookings.

The outlook for post-pandemic recoveries continued to
diverge between the U.S. and Europe.

President Joe Biden's order to make vaccination available to
all adults by May 1 contrasted with stuttering rollouts in
Germany, France and elsewhere, where use of the AstraZeneca
vaccine has been suspended amid concern over possible
side effects.

However, Kyle Rodda, an analyst at IG Markets, said the
prospect of a slower economic recovery in Europe didn't appear
to be a major handicap for investors.

"It doesn't seem to be the view that this is a real risk,"
he said. "Investors are wary, but not worried."

In currencies, the U.S. dollar held small gains from
overnight, with caution evident ahead of the central bank
meetings.

The dollar was largely flat at 109.19 yen, after
rising as high as 109.365 on Monday for the first time since
June.

The euro was little changed at $1.1930, holding for
an eighth session below the $1.20 level.

Bitcoin halted its slide from a record high of
$61,781.83 reached on Saturday, last trading 1% higher on the
day around $56,250.

U.S. West Texas Intermediate crude for April changed
hands at $64.74 a barrel, down 1%. Brent crude futures
for May stood at $68.22 a barrel, losing 1%.

(Reporting by Ritvik Carvalho; additional reporting by Kevin
Buckland and Kane Wu in Tokyo; editing by Larry King)

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.